<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

3 min read

Extremities Outlook for 2024

By Lisa Mahan on 2/27/24 9:30 AM

SmartTRAK takes a look at the trends impacting the Extremities Market in 2024 and beyond.

SmartTRAK provides comprehensive insights into the key trends shaping the US Extremities Market, with a particular focus on upper extremities and foot & ankle sectors. Reimbursement changes, the competitive landscape of robotics and innovative advancements in fixation technologies are poised to dominate discussions, underscoring the dynamic evolution of this market segment.
 

Among the many topics covered in detail in this market outlook article are:

  • CMS Reimbursement Changes Accelerate Shift to Arthroplasty Site-of-Care
    The Centers for Medicare and Medicaid Services’ (CMS) move to reimburse shoulder replacement and ankle replacement in an ambulatory surgery center (ASC) setting will accelerate the move of procedures to ... (read more)

  • An Increase in Pricing Pressure from the Shift to Shoulder ASC Procedures
    The national average CMS facility reimbursement in 2024 for total shoulder arthroplasty in an ASC is approximately $14K, significantly lower than for hospital-based procedures in the range of ... (read more)

  • The Race is on for Shoulder Robotics
    Stryker and Zimmer Biomet appear to be racing to the finish line to be the first to market in the US with a shoulder robotics solution. During Zimmer Biomet’s Q323 earnings call, CEO Ivan Tornos stated they plan to be first on ... (read more)
Continue Reading
3 min read

Statera Medical: Smart Shoulder Implant - An Interview with Samuel Bourdon

By Nick Fitzpatrick on 8/11/23 11:46 AM

Samuel Bourdon, Co-Founder and Chief Executive Officer of Statera Medical discusses Statera Medical’s development of a smart shoulder implant.

In an interview withSmartTRAK,Samuel Bourdon, the Co-Founder and Chief Executive Officer of Statera Medical, discusses how Statera Medical came to be, why their focused on creating a smart implant for the shoulder arthroplasty market and where he sees the Company going in the future.

To find out more, including the design rationale behind Statera’s smart shoulder ecosystem and how Statera fits in the shoulder arthroplasty market, click on the following video to listen to the full interview (29:25). If you would like to download the complete transcript of the interview, click here.


SmartTRAK: Hey guys, this is Nick with SmartTRAK. I'm here with Samuel Bourdon, CEO and founder of Statera Medical. I appreciate you joining me this morning and doing this interview. Samuel, can you give us an introduction about your yourself and a brief background of your experience in the orthopedics industry?


Samuel Bourdon: I'm a mechanical engineer by training. I have worked in product development since 2012 and mostly in the aerospace and recreational product. And when I turned 30, I quit my job and decided to go back to school to do a full-time master degree in biomedical engineering. And then I managed to do a master in business administration part-time during the same period. So before Statera Medical I had no experience in orthopedic industry at all, so it's a first time for me.

That's definitely monumental. Why'd you switch from aerospace to biomedical?

SB: Yeah, I just hit a bigger why in my career and I wanted to put a human at the center of it, so that's what made me took that decision.

Where did you get your master's in biomed from?

SB: From Polytechnique Montreal. It's the same university I got my mechanical engineer degree.

Let's dive into the company that you founded, Statera Medical. So what was the inspiration behind founding Statera Medical, and what's your mission statement behind it?

SB: What happened is I met another engineer and an orthopedic surgeon, and it was really all about reducing complication rates and improving patient outcomes, which ultimately results in ...

To download the complete transcript of SmartTRAK's interview with Samuel Bourdon, the Co-Founder and CEO of Statera Medical, just click the button below. Download the Transcript

Continue Reading
2 min read

Healthy Growth: Q123 Trauma Market Recap

By Natasha Weeks on 7/24/23 9:28 AM

Strong returns in IM Nailing and a flurry of activity in the Pediatric space results in a healthy Q123 for the Trauma Market

The US Trauma Market grew +6.0% in Q123 fueled by new product adoption. While headwinds such as supply chain constraints, economic challenges and staffing shortages could darken the forecast, SmartTRAK expects the Trauma Market will not be as heavily impacted as its elective procedure counterparts and should continue to experience healthy growth through 2023 as many manufacturers note Q1 results are in line with pre-Covid historical trends.
 
Among the many topics covered in detail in SmartTRAK 's comprehensive Q123 Trauma Market Recap *  are:
  • Complete Q123 Trauma Market Overview
  • SmartTRAK's Expert Market Analysis and Insights
  • All Trauma Companies' News, Revenues, Data, Charts and Market Shares
  • IM Nailing Closes the Quarter on High with Solid Returns
  • New Regulatory Clearances Propel the Pediatric Trauma Segment:
    • OrthoPediatrics
    • NuVasive Specialized Orthopedics, Inc.
    • Wishbone Medical
  • Q123 Trauma Regulatory Highlights

During Q1, the Pediatric Trauma segment experienced a notable surge in regulatory clearances, indicating forthcoming product launches aimed at bolstering the segment's growth. These approvals signal  ...

Read the entire Q123 Trauma Market Recap, including SmartTRAK's expert analysis, news, data, charts, revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below. Learn More about Subscribing to SmartTRAK


Continue Reading
2 min read

Advancements and Innovations In Bio-Integrative Fixation: An Interview with Orahn Preiss-Bloom

By Andy Knapik on 7/13/23 9:48 AM

Orahn Preiss-Bloom, founder and Chief Innovation Officer of Ossio Ltd. discusses Osssio’s advancements in innovations in the world of bio-integrative fixation devices.

In an interview with SmartTRAK, Orahn Preiss-Bloom, the founder and Chief Innovation Officer of Ossio Ltd, discusses how Ossio came to be, what makes their products different and where he sees the Company going in the future.

To find out more about Ossio, click on the following video to watch the interview (24:42 min). To download a complete transcript of the interview, click here. For more details, interview topics by timecode are provided below.

Interview Topics By Timecode

00:44 Orahn’s background in the medical industry.
03:53 What differentiates the OSSIO product.
07:55 Initial uses for OSSIOfiber.
12:40 Overcoming surgeon objections to biointegrative materials.
15:13 Ossio education labs.
19:44 Ossio in sports medicine.
22:41 Surgeon concerns.

To download the complete transcript of the interview with Orahn Preiss-Bloom, Founder and Chief Innovation Officer of Ossio Ltd, just click the button below. Download the Interview Transcript

Continue Reading
9 min read

What's New in Orthopedics Research & Development

By Thomas Wallick on 2/27/23 11:28 AM

In recent years, there have been significant advances in orthopedic treatments, surgical techniques and rehabilitation methods that have transformed the way we approach musculoskeletal disorders.SmartTRAK continues to report daily, in real-time on the challenges still ahead, covering all aspects of the Orthopedic market: Extremities, OrthoBio, Spine, Computer Assisted Surgery, Total Joints, Trauma, Soft Tissue Fixation and EU Extremities and Trauma.

SmartTRAK features curated content by our team of industry experts, bringing the most relevant information and insight directly to you in real-time. Learn about the latest news, emerging technologies or start-ups to watch, conference happenings and more via articles, videos and interviews and Be The Expert.

The following is just a small sampling of recent Orthopedic updates from around the world compiled, reviewed and posted daily by our SmartTRAK analysts.

New Products:

  • NuVasive*

    NUVA spoke about its upcoming product launches, including an expandable Lateral called MOD-EX XLIF and extended blade-fixation options for Modulus ALIF, and predicted that both will support the continued interest in NUVA. NUVA Q422 Earnings Transcripton Seeking Alpha

  • GMED mgmt stated the ortho robot will launch w/ a knee application first w/ other applications to follow, noting it is unlikely that gap-filling joint implant systems would be launched prior to the knee application for robotics. GMED Q422 Earnings Transcript on Seeking Alpha

  • CurvaFix announced a it will launch the 7.5 mm CurvaFix IM Implant, which received FDA clearance in Oct 2022, at this year’s AAOS annual meeting in Las Vegas. BusinessWire

Patents:

  • SeaSpine*

    7D Surgical was granted US Patent “Systems And Methods For Intraoperative Spinal Level Verification” disclosing the use of segmented surface data from volumetic pt image data compared w/ intra-op surface data to verify spine levels w/o x-rays. 11564752

  • Method for Treating Joint Pain  

    US Patent "Method for treating joint pain" was granted relating to treating joint pain by inserting a bone dowel and BMA into the subchondral of a bone and introducing BMA into the intra-articular space of the joint being treated. 11583402

Continue Reading
2 min read

2023 Extremities Trends to Watch

By Lisa Mahan on 2/21/23 12:17 PM

SmartTRAK highlights trends affecting the US Extremities Market in 2023

The Extremities Market continues to be a hotbed of activity heading into 2023. SmartTRAK highlights trends that will continue to affect the US Market for Extremities in 2023, including CMS reimbursement obstacles, new product introductions and potential mergers and acquisitions.
 

Among the many topics covered in detail in this comprehensive article are:

  • SmartTRAK's Expert Market Analysis and Insights
  • Outpatient Shoulder Replacement Growing Despite Lack of CMS Reimbursement
  • New Shoulders May Heat Up Competition
  • New Ankle Products and Technologies May Boost Growth
  • New Products, DTC and Potential M&As Heat Up Extremities Fixation
  • M&As on the Horizon

To download and read the complete "2023 Extremities Trends to Watch" article, just click the button below.Download the Extremities Trends Article

The countdown to AAOS 2023 on March 7-11 in Las Vegas has begun and the SmartTRAK team will be attending...see you there!

Continue Reading
3 min read

The Future of PEKK in Orthopedics: An Interview w/ Oxford Performance Materials' Scott Felice

By Nick Fitzpatrick on 1/23/23 10:18 AM

SmartTRAK interviews Oxford Performance Materials CEO Scott DeFelice to learn more about the company’s PEKK-based materials solutions in orthopedics.

In an interview with   SmartTRAK, Oxford Performance Materials’ (OPM) CEO Scott DeFelice explains the history of his company, the difference between PEKK, PEEK and titanium-based implants and the Company’s future plans in the orthopedic space.

To find out more, including OPM’s plan to expand into the custom trauma market and its planned release of an all-polymer total knee, just click on the following video to listen to the full interview. (29:13 min).  A link to download a transcript of the complete interview is also provided below.

Continue Reading
2 min read

New Products and Easier Comps Drive US Growth: Q322 Trauma Market Recap

By Natasha Weeks on 1/3/23 9:30 AM

Despite declining OUS results, the US Trauma Market experienced healthy growth attributed to adoption of new products.

While OUS results declined in Q322 due to foreign currency headwinds and China’s value-based pricing, the US drove the overall market through product penetration and easier comps due to the Q321 COVID waves that impacted procedural volumes last year. Companies posted healthy US growth, attributing new products for driving growth, with plans for additional launches in Q4 and 2023.

Among the many topics covered in detail in our comprehensive Q322 Trauma Market Recap* are:

Continue Reading
10 min read

What's New in Trauma and Extremities?

By Natasha Weeks on 12/5/22 10:12 AM

In the market for Trauma & Extremities, companies continue to innovate with new product introductions as well as a value-based care approach that promotes supporting clinical evidence for new and existing products showing their benefits to the patient and the hospital. Manufacturers are investing in solutions beyond implants to differentiate themselves and gain share in the Trauma & Extremities markets. SmartTRAK has observed a variety of strategies and solutions in the fast-paced hallux valgus segment as well as investment in deformity correction and periprosthetic solutions. The following is a sample of SmartTRAK's recent Trauma & Extremities news and developments from around the world, compiled, curated and posted in real-time by the expert analysts at SmartTRAK.

We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, new products, patents, financial data and competitor developments in the global Life Sciences industry. If you'd like to receive these expert insights daily, Contact Us to learn more. Our users think it's the perfect way to start their day.

New Products:

  • CAPTIVATE Cannulated Screw System* - Globus*

    Globus announced the launch of the CAPTIVATE Headed Cannulated Screw System in diameters 2.5/3.0 mm, 3.5/4.0 mm, 4.5/5.5 mm. SmartTRAK reviewed the products at OTA with Globus as the Company fills out its Trauma & Extremities portfolio. LinkedIn

  • Stryker launched the Gamma4 System, the next-gen IM nail system from the IM Nail market leader (45.6% US share in 2021) according to SmartTRAK’s Financial Dashboard. The new system features a precision pin, redefined nail design and integrated instrument.

Continue Reading
1 min read

Trends and Advancements in Foot & Ankle: AOFAS 2022

By Natasha Weeks on 11/17/22 9:38 AM

SmartTRAK highlights new products and Company strategies to penetrate the Foot & Ankle space at AOFAS 2022

SmartTRAK identified several key themes and takeaways from the American Orthopaedic Foot & Ankle Society (AOFAS) 2022 meeting held recently in Quebec City, Canada. Manufacturers showcased product introductions with a continued focus on hallux valgus solutions and are investing in solutions beyond implants to differentiate themselves and gain share in the US Foot & Ankle Market.

Among the many topics covered in detail in the complete article, which can be downloaded here, are:

  • Small, Niche Players Attempt to Gain Share
    • Globus Fills Out Trauma and Extremities Product Portfolios
    • Enovis Showcases New Products and Gains Traction in F&A Space
  • Direct-To-Consumer Marketing Drives Growth in Hallux Valgus Market
    • Treace Medical Outpaces Others
    • Medartis Showcases New Products
    • JNJ/DePuy/Synthes' Acquisition
    • Paragon28 Focuses on the MIS Segment

To download the complete "AOFAS 2022: Trends and Advancements in Foot & Ankle" article by SmartTRAK's Natasha Weeks, Sr. Analyst, Trauma & Extremities, just click the button below.Download the AOFAS 2022 Article

Continue Reading
  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles